These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7030942)
61. Studies of reactivity of some Sri Lankan population groups to antigens of Mycobacterium leprae. I. Reactivity to lepromin A. Pinto MR; Eriyagama NB; Pemajayantha V Lepr Rev; 1987 Jun; 58(2):105-18. PubMed ID: 3302577 [No Abstract] [Full Text] [Related]
62. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report. Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437 [TBL] [Abstract][Full Text] [Related]
63. Significance of antibody studies in leprosy and experimental models of the disease. Harboe M Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):342-50. PubMed ID: 6754640 [No Abstract] [Full Text] [Related]
64. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction. Gill HK; Mustafa AS; Godal T Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799 [TBL] [Abstract][Full Text] [Related]
65. Immunity to leprosy and the Mitsuda reaction. Shepard CC Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):74-7. PubMed ID: 6368430 [No Abstract] [Full Text] [Related]
66. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. Convit J; Aranzazu N; Pinardi M; Ulrich M Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331 [TBL] [Abstract][Full Text] [Related]
67. Impact of combined Mycobacterium w vaccine and 1 year of MDT on multibacillary leprosy patients. De Sarkar A; Kaur I; Radotra BD; Kumar B Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):187-94. PubMed ID: 11875762 [TBL] [Abstract][Full Text] [Related]
68. Electron microscope study of Erythema nodosum leprosum. Okada S; Nakai E; Narita M; Takahashi S; Harada N Int J Lepr Other Mycobact Dis; 1974; 42(1):33-7. PubMed ID: 4137644 [No Abstract] [Full Text] [Related]
69. An attempt to induce a histological ENL symptom in M. leprae infected nude mice. Subowo Nihon Rai Gakkai Zasshi; 1986; 55(4):173-85. PubMed ID: 3323158 [No Abstract] [Full Text] [Related]
70. Vaccine trials in leprosy--Venezuela, Malawi and India. Gupte MD Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S32-7. PubMed ID: 10700935 [No Abstract] [Full Text] [Related]
71. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria. Sharma RC; Singh R Lepr India; 1978 Oct; 50(4):572-8. PubMed ID: 374876 [No Abstract] [Full Text] [Related]
72. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions. Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587 [TBL] [Abstract][Full Text] [Related]
73. Filter paper blood spot test for detection of anti-ND-BSA antibodies in school children. Sahasrabudhe R; Dandekar S; Shah DH; Naik S; Ganapathi R Indian J Med Res; 1992 May; 95():105-11. PubMed ID: 1506059 [TBL] [Abstract][Full Text] [Related]
74. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report. Godal T; Myrvang B; Samuel DR; Ross WF; Lofgren M Acta Pathol Microbiol Scand Suppl; 1973; 236(0):45-53. PubMed ID: 4602874 [No Abstract] [Full Text] [Related]
75. Epidemiological studies in children of a low-endemic region, a high-endemic region, and dwellers of a leprosy colony: evaluation of anti-ND-BSA antibodies and lepromin response. Shah DH; Vartak RR; Naik SS; Dandekar SR; Ganapati R Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):539-46. PubMed ID: 7868951 [TBL] [Abstract][Full Text] [Related]
76. ICRC vaccine-induced changes in M. leprae-specific cell-mediated immunity in langur (Presbytis entellus) monkeys. Chirmule NB; Deo MG; Sirodkar MV; Deshmukh R; Chanderkar NG Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):57-62. PubMed ID: 3519805 [TBL] [Abstract][Full Text] [Related]
77. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma. Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450 [TBL] [Abstract][Full Text] [Related]
78. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients]. Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714 [TBL] [Abstract][Full Text] [Related]
79. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia. Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462 [TBL] [Abstract][Full Text] [Related]
80. [Epidemiological immunological studies on leprosy in Okinawa. III. Reactivity to the standard and diluted lepromins of leprosy patients in the mainland and Okinawa]. Abe M; Kawaguchi Y; Kobayashi S; Hokibara H; Saikawa K; Baba S; Ide J Nihon Rai Gakkai Zasshi; 1988; 57(2):87-98. PubMed ID: 3072330 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]